2026 NPPES data Diagnostic Neuroimaging (Psychiatry & Neurology) Physician NPI 1154324986 M.D.,M.R.C.P.(U.K)
Verify on CMS →

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)

Diagnostic Neuroimaging (Psychiatry & Neurology) Physician in TITUSVILLE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 207 beneficiaries · Diagnostic Neuroimaging (Psychiatry & Neurology) Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$203.96
11 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) filed 1,046 Medicare Part D claims in 2023 as a Diagnostic Neuroimaging (Psychiatry & Neurology) Physician in TITUSVILLE, Florida, prescribing 95% generic.

1K
Part D claims, 2023
95%
generic prescribing
$203.96
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,046 Top 24% higher than 76% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)?

Quality data not reported

NPI registry status

Active

Issued 05/24/2005

NPI 1154324986

Primary specialty

Diagnostic Neuroimaging (Psychiatry & Neurology) Physician

Rare

30 US NPIs in this specialty

Medicare Part D claims

1,046 9% vs specialty avg

2023 prescription claims

Specialty avg: 1,149

Specialty distribution in Florida

How Diagnostic Neuroimaging (Psychiatry & Neurology) Physician compares to other specialties among Florida providers

Florida providers

Diagnostic Neuroimaging (Psychiatry & Neurology) Physician share within Florida

1. Diagnostic Neuroimaging (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Diagnostic Neuroimaging (Psychiatry & Neurology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician ABMS/AOA estimate

Est. board-certified rate (Diagnostic Neuroimaging (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Diagnostic Neuroimaging (Psychiatry & Neurology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) appears in the CMS NPPES registry as a Diagnostic Neuroimaging (Psychiatry & Neurology) Physician provider holding M.D.,M.R.C.P.(U.K) credentials at 951 N WASHINGTON AVE, TITUSVILLE, FL, 32796, with a listed phone of (321) 268-6111. NPI 1154324986 was issued on 05/24/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what D'CRUZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,046 prescription claims written by this provider, covering 207 Medicare beneficiaries and totaling roughly $150K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Diagnostic Neuroimaging (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 30 enrolled providers across 16 states and an average of 1,149 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

951 N WASHINGTON AVE
TITUSVILLE, FL 32796

Provider Details

NPI 1154324986
Specialty Diagnostic Neuroimaging (Psychiatry & Neurology) Physician
Credentials M.D.,M.R.C.P.(U.K)
Gender Male
NPI Issued 05/24/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K). Source: openpaymentsdata.cms.gov.

Total received

$204

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K). To verify ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 1,046 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,046
Total Claims
$150K
Total Drug Cost
207
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,910
Total Day Supply
56,227
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$97K
Generic Drug Cost
$53K
Opioid Claims
15 (1.4% rate)

Patient Demographics

Average Patient Age
70.1 years
Avg HCC Risk Score
1.47
Gender Split
52% female / 48% male
Age Distribution
<65: 41, 65-74: 86, 75-84: 60, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levetiracetam
118
Gabapentin
109
Carbidopa-Levodopa
Carbidopa/Levodopa
108
Nortriptyline Hcl
69
Donepezil Hcl
66
Topiramate
55
Phenobarbital
35
Carbidopa-Levodopa Er
Carbidopa/Levodopa
34
Sumatriptan Succinate
30
Lacosamide
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Diagnostic Neuroimaging (Psychiatry & Neurology) Physician Overview

How ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) fits within the Diagnostic Neuroimaging (Psychiatry & Neurology) Physician landscape nationally.

30
Diagnostic Neuroimaging (Psychiatry & Neurology) Physician Providers in US
16
States with Diagnostic Neuroimaging (Psychiatry & Neurology) Physician
1,149
Avg Claims per Provider

ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s 1,046 claims are below the specialty average of 1,149.

Nearby Diagnostic Neuroimaging (Psychiatry & Neurology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as D'CRUZ.

Compare Diagnostic Neuroimaging (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s specialty?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) specializes in Diagnostic Neuroimaging (Psychiatry & Neurology) Physician and practices in TITUSVILLE, Florida. Credentials: M.D.,M.R.C.P.(U.K).
How much does ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) prescribe under Medicare Part D?
In 2023, ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) wrote 1,046 Medicare Part D claims totaling $150K in drug costs for 207 beneficiaries.
Where is ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) located?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) is located at 951 N WASHINGTON AVE, TITUSVILLE, FL, 32796. Phone: (321) 268-6111.
What is ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s NPI number?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s National Provider Identifier (NPI) is 1154324986, issued on 05/24/2005.
Does ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) prescribe more brand-name or generic drugs?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $97K in brand drug costs.
Does ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) prescribe opioids?
Yes, ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) had 15 opioid claims in 2023 with an opioid prescribing rate of 1.4%.
How many Diagnostic Neuroimaging (Psychiatry & Neurology) Physician providers are there in the US?
There are 30 Diagnostic Neuroimaging (Psychiatry & Neurology) Physician providers across 16 states in the US. The average Diagnostic Neuroimaging (Psychiatry & Neurology) Physician provider writes 1,149 Medicare Part D claims per year.
What drugs does ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) prescribe most often?
Based on 2023 Medicare Part D data, ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s most frequently prescribed drugs include Levetiracetam, Gabapentin, Carbidopa-Levodopa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) accept Medicare?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K) appears in CMS Medicare data with 1,046 Part D claims and 207 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s credentials?
ARVIND D'CRUZ, M.D.,M.R.C.P.(U.K)'s NPI is 1154324986 with credentials M.D.,M.R.C.P.(U.K). You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology